Literature DB >> 17436113

Role of functional magnetic resonance imaging in drug discovery.

Martin P Paulus1, Murray B Stein.   

Abstract

In this review, we survey the state of the field of functional magnetic resonance imaging (fMRI) as it relates to drug discovery and drug development. We highlight the advantages and limitations of fMRI for this purpose and suggest ways to improve the use of fMRI for developing new therapeutics, with emphasis on treatments for anxiety disorders. Fundamentally, pharmacological studies with standard psychiatric treatments using standardized behavioral probes during fMRI will need to be carried out to determine characteristic brain signatures that could be used to predict whether novel compounds are likely to have specific therapeutic effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17436113      PMCID: PMC2841045          DOI: 10.1007/s11065-007-9023-0

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  69 in total

1.  Explicit and incidental facial expression processing: an fMRI study.

Authors:  M L Gorno-Tempini; S Pradelli; M Serafini; G Pagnoni; P Baraldi; C Porro; R Nicoletti; C Umità; P Nichelli
Journal:  Neuroimage       Date:  2001-08       Impact factor: 6.556

2.  Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation.

Authors:  S Ogawa; T M Lee
Journal:  Magn Reson Med       Date:  1990-10       Impact factor: 4.668

3.  Brief breath holding may confound functional magnetic resonance imaging studies.

Authors:  David F Abbott; Helen I Opdam; Regula S Briellmann; Graeme D Jackson
Journal:  Hum Brain Mapp       Date:  2005-04       Impact factor: 5.038

4.  Social anxiety predicts amygdala activation in adolescents viewing fearful faces.

Authors:  William D S Killgore; Deborah A Yurgelun-Todd
Journal:  Neuroreport       Date:  2005-10-17       Impact factor: 1.837

5.  Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult.

Authors:  Cornelius Gross; Xiaoxi Zhuang; Kimberly Stark; Sylvie Ramboz; Ronald Oosting; Lynn Kirby; Luca Santarelli; Sheryl Beck; René Hen
Journal:  Nature       Date:  2002-03-28       Impact factor: 49.962

6.  Amygdala response to fearful faces in anxious and depressed children.

Authors:  K M Thomas; W C Drevets; R E Dahl; N D Ryan; B Birmaher; C H Eccard; D Axelson; P J Whalen; B J Casey
Journal:  Arch Gen Psychiatry       Date:  2001-11

7.  A neuromodulatory role for the human amygdala in processing emotional facial expressions.

Authors:  J S Morris; K J Friston; C Büchel; C D Frith; A W Young; A J Calder; R J Dolan
Journal:  Brain       Date:  1998-01       Impact factor: 13.501

8.  Amygdala responses to human faces in obsessive-compulsive disorder.

Authors:  Paul A Cannistraro; Christopher I Wright; Michelle M Wedig; Brian Martis; Lisa M Shin; Sabine Wilhelm; Scott L Rauch
Journal:  Biol Psychiatry       Date:  2004-12-15       Impact factor: 13.382

Review 9.  Neuroanatomical circuits modulating fear and anxiety behaviors.

Authors:  D S Charney
Journal:  Acta Psychiatr Scand Suppl       Date:  2003

10.  Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces.

Authors:  Roshan Cools; Andy J Calder; Andrew D Lawrence; Luke Clark; Ed Bullmore; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

View more
  8 in total

Review 1.  Role of neuroimaging in analgesic drug development.

Authors:  Jane Lawrence; Sean C Mackey
Journal:  Drugs R D       Date:  2008

2.  Pregabalin influences insula and amygdala activation during anticipation of emotional images.

Authors:  Robin L Aupperle; Lakshmi Ravindran; Dharol Tankersley; Taru Flagan; Nathan R Stein; Alan N Simmons; Murray B Stein; Martin P Paulus
Journal:  Neuropsychopharmacology       Date:  2011-03-23       Impact factor: 7.853

3.  Cognitive Control, the Anterior Cingulate, and Nicotinic Receptors: A Case of Heterozygote Advantage.

Authors:  Jason Smucny
Journal:  J Neurosci       Date:  2018-01-10       Impact factor: 6.167

4.  Dynamic changes in amygdala activation and functional connectivity in children and adolescents with anxiety disorders.

Authors:  Johnna R Swartz; K Luan Phan; Mike Angstadt; Kate D Fitzgerald; Christopher S Monk
Journal:  Dev Psychopathol       Date:  2014-11

5.  Altered activation of the rostral anterior cingulate cortex in the context of emotional face distractors in children and adolescents with anxiety disorders.

Authors:  Johnna R Swartz; K Luan Phan; Mike Angstadt; Heide Klumpp; Kate D Fitzgerald; Christopher S Monk
Journal:  Depress Anxiety       Date:  2014-07-03       Impact factor: 6.505

6.  Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.

Authors:  Amit Etkin; Tor D Wager
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

7.  Subchronic SSRI administration reduces insula response during affective anticipation in healthy volunteers.

Authors:  Alan N Simmons; Estibaliz Arce; Kathryn L Lovero; Murray B Stein; Martin P Paulus
Journal:  Int J Neuropsychopharmacol       Date:  2009-06-23       Impact factor: 5.176

8.  Pregabalin effects on neural response to emotional faces.

Authors:  Robin L Aupperle; Dharol Tankersley; Lakshmi N Ravindran; Taru Flagan; Nathan R Stein; Murray B Stein; Martin P Paulus
Journal:  Front Hum Neurosci       Date:  2012-03-27       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.